Predictors of new onset atrial fibrillation in patients with heart failure

被引:10
|
作者
Campbell, Niall G. [1 ]
Cantor, Emily J. [1 ]
Sawhney, Vinit [1 ]
Duncan, Edward R. [1 ]
DeMartini, Chiara [1 ]
Baker, Victoria [1 ]
Diab, Ihab G. [1 ]
Dhinoja, Mehul [1 ]
Earley, Mark J. [1 ]
Sporton, Simon [1 ]
Davies, L. Ceri [1 ]
Schilling, Richard J. [1 ]
机构
[1] Queen Mary Univ London, St Bartholomews Hosp, Cardiol Res Dept, London, England
关键词
Atrial fibrillation; Heart failure; Ischaemic heart disease; Implantable defibrillator; Renal impairment; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CHRONIC KIDNEY-DISEASE; FOLLOW-UP; MANAGEMENT; MORTALITY; RISK; ABLATION;
D O I
10.1016/j.ijcard.2014.05.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Stroke associated with atrial fibrillation (AF) is more frequent in heart failure. It is unknown what variables predict future AF in these patients and how AF might evolve over time. We investigated this in patients with implantable cardiac defibrillators (ICD) where AF detection is optimal. Methods: Single centre, retrospective, observational cohort study. All ischaemic cardiomyopathy patients with dual chamber, primary prevention ICD implants between Aug 2003 and Dec 2009 were screened and included if at implant, they had no known AF history. Nine variables were analysed. AF was defined as any atrial tachyarrhythmia >= 180 bpm and >= 30 s. Multivariable, binary logistic regression models were built by adding variables significant in the univariate models. Variables were retained in the final multivariate models if p < 0.05. Results: n = 197 met the inclusion criteria (85.8% male, median age: 66.8 years). After median follow-up for 2.8 years, 44.2% developed AF. After univariate analysis, the baseline variables associated with AF after implant were age, NYHA class and renal impairment (RI, defined eGFR < 60 ml/min/1.73 m(2)) (p < 0.05). After multivariable analysis, the only variable which was associated with AF was RI (HR: 2.04 (CI: 1.10-3.79)). Two baseline variables were independently associated with all-cause mortality: RI (HR: 2.42 (1.14-5.12)) and non-white ethnicity. Conclusion: RI at time of implant was independently associated with both future AF and all-cause mortality during long-term follow-up. RI was a stronger predictor of AF than age. Those patients with heart failure and RI should be regularly screened for asymptomatic AF, regardless of age, to ensure that stroke prophylaxis may be initiated. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:328 / 332
页数:5
相关论文
共 50 条
  • [21] Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients
    Hu, Yu-feng
    Liu, Chia-jen
    Chang, Peter Mu-hsin
    Tsao, Hsuan-ming
    Lin, Yenn-jiang
    Chang, Shih-lin
    Lo, Li-wei
    Tuan, Ta-chuan
    Li, Cheng-hung
    Chao, Tze-fan
    Chung, Fa-po
    Liao, Jo-nan
    Chen, Tzeng-Ji
    Chen, Shih-ann
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 165 (02) : 355 - 357
  • [22] Predictors of new-onset atrial fibrillation in geriatric trauma patients
    Marco, Catherine A.
    Lynde, Jennifer
    Nelson, Blake
    Madden, Joshua
    Schaefer, Adam
    Hardman, Claire
    McCarthy, Mary
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2020, 1 (02) : 102 - 106
  • [23] Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time
    Buck, Sandra
    Rienstra, Michiel
    Maass, Alexander H.
    Nieuwland, Wybe
    Van Veldhuisen, Dirk J.
    Van Gelder, Isabelle C.
    EUROPACE, 2008, 10 (05): : 558 - 565
  • [24] Permanent Atrial Fibrillation in Patients with Paroxysmal or Persistent Atrial Fibrillation and Diastolic Chronic Heart Failure: Echocardiographic Predictors
    Tunyan, Lusine
    Grigoryan, Svetlana
    CIRCULATION, 2010, 122 (02) : E209 - E209
  • [25] New Onset Atrial Fibrillation Is a Risk Factor for Ventricular Arrhythmias in Heart Failure
    Aleong, Ryan
    Sauer, William H.
    Davis, Gordon
    Bristow, Michael R.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S24 - S24
  • [26] Dapagliflozin effect on heart failure with prevalent or new-onset atrial fibrillation
    Arita, Vicente Artola
    Van Veldhuisen, Dirk J.
    Rienstra, Michiel
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (03) : 526 - 528
  • [27] Aggressive combined pharmacotherapy for heart failure reduces new onset atrial fibrillation
    Tokutome, M.
    Matsukawa, R.
    Noma, A.
    Kisanuki, H.
    Nakashima, H.
    Watanabe, T.
    Sakemi, T.
    Okabe, K.
    Okahara, A.
    Kawai, S.
    Matsuura, H.
    Masuda, S.
    Mukai, S.
    EUROPEAN HEART JOURNAL, 2022, 43 : 957 - 957
  • [28] A Case Study Of Dilated Cardiomyopathy With A New Onset Atrial Fibrillation And Heart Failure
    Beirne, J.
    Brauns, R.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S66 - S67
  • [29] Atrial fibrillation in patients with heart failure
    Hynes, BJ
    Luck, JC
    Wolbrette, DL
    Bhatta, L
    Khan, M
    Samii, S
    Naccarelli, GV
    CURRENT OPINION IN CARDIOLOGY, 2003, 18 (01) : 32 - 38
  • [30] Atrial fibrillation in patients with heart failure
    Diaconu, C. C.
    Berceanu, D.
    Bucur, D.
    Dediu, G. N.
    Iancu, M. A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 251 - 251